Madrid Rallies Against Cancer with Massive Charity Race

Approximately 35,000 participants gathered on Paseo de la Castellana for the XIII Madrid in March Against Cancer Race, organized by the AECC.

Generic image of a crowd of runners in an urban race.
IA

Generic image of a crowd of runners in an urban race.

The XIII Madrid in March Against Cancer Race brought together nearly 35,000 runners on Paseo de la Castellana, emphasizing the importance of prevention and healthy habits in the fight against the disease.

The Spanish capital witnessed a significant civic mobilization with the celebration of the XIII Madrid in March Against Cancer Race. The event, held on Paseo de la Castellana, gathered approximately 35,000 individuals who participated in various modalities to support the cause.
Organized by the Spanish Association Against Cancer (AECC), the race featured two main routes: a 10-kilometer course for advanced runners and a 4.5-kilometer option accessible to participants of all levels, including those who chose to walk. Additionally, the day included non-competitive children's races in the Jardines del Descubrimiento and a family activity area in Plaza de Colón.

"Prevention and health promotion, along with maintaining healthy habits, are fundamental in the fight against cancer."

a delegate for Social Policies
A local government representative highlighted the importance of prevention and adopting healthy lifestyles. In this context, the existing agreement between the City Council and the AECC was recalled, aimed at conducting talks, workshops, and awareness campaigns on the risks of tobacco to prevent and control its consumption.
The AECC, founded in 1953, is a non-profit organization comprising patients, families, volunteers, and professionals. Its mission is to improve the quality of life for those affected by cancer. The association has set a goal for 2030 to achieve a 70% survival rate, for which it plans an investment exceeding 143 million euros, the largest in its history, to fund over 750 research projects involving 1,500 researchers.